BACKGROUND
Despite lack of adequate, validated, independently performed clinical studies, several molecular tests are commercially available on the market and are being used on indeterminate thyroid nodules to guide patient-care decisions.
METHODS
We summarize the current evidence on the role and limitations of molecular tests used in combination with thyroid cytopathology to refine the presu...
